 |
Listen to Your HeartAuthor: Listen to Your Heart
Advances in cardiovascular care are continuously being made, with new research, new treatments, and new recommendations for best practice. Listen to Your Heart is a series of in-depth conversation with experts who are at the forefront of cardiovascular research and medicinepreventing, diagnosing, and treating cardiovascular disease for better patient outcomes. We're starting the conversation with those who are committed to improving heart health for all, and to help provide important information and insight for fellow healthcare professionals keen to target the needs of their patients, particularly those at high-risk for cardiovascular disease. This podcast is intended for healthcare professionals only. Speaker disclosures are available in each episodes notes. The views and opinions expressed in this program are those of the speakers and do not necessarily reflect the views or positions of any entities they represent. Some information contained here may cite the use of an unapproved product in a dosage, for an indication, or in a manner other than recommended. Before prescribing any product always refer to the latest Product Monograph. Financial support for the Listen to Your Heart program was provided by Sanofi Canada. MAT-CA-2201005 Language: en Genres: Health & Fitness, Life Sciences, Science Contact email: Get it Feed URL: Get it iTunes ID: Get it |
Listen Now...
Beyond LDL, lipoprotein A: Role and impact on ACS
Episode 1
Tuesday, 21 October, 2025
How is the evolving understanding of lipoprotein A reshaping our approach to prevention of heart disease?Our host, Dr. Michael Levi, takes a deep dive into this topic with Dr. Lior Bibas, a cardiologist and critical care physician at Pierre Boucher Hospital and the Montreal Heart Institute.In this episode, our experts explain why lipoprotein A is gaining prominence as a key risk factor for cardiovascular disease, discussing its unique properties and clinical implications. They share insights from their clinical practices, revealing how a deeper understanding of specific lipid markers is influencing both primary and secondary prevention strategies and aggressive treatment decisions. Tune in for a glimpse into the future of personalized heart care and emerging therapies that could transform treatment.Don’t miss the conversation! The views and opinions expressed in this episode are those of the speakers and do not necessarily reflect the views or positions of any entities they represent. Declaration of conflict of interest: Dr. Michael Levi:· None.Dr. Lior Bibas:· None. MAT-CA-2501196 V(1.0) App 09/25
